Friday, August 8, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Korea University College of Medicine’s team facilitates personalized treatment opportunities for malignant brain tumor, glioblastoma

May 10, 2024
in Cancer
Reading Time: 3 mins read
0
Korea University College of Medicine’s team facilitates personalized treatment opportunities for malignant brain tumor, glioblastoma
66
SHARES
602
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT
ADVERTISEMENT

A pioneering study has been released, showcasing the first-ever uncovering of the evolutionary dynamics of glioblastoma recurrence through proteogenomic analysis, offering potential therapeutic avenues.

A pioneering study has been released, showcasing the first-ever uncovering of the evolutionary dynamics of glioblastoma recurrence through proteogenomic analysis, offering potential therapeutic avenues.

 

The research team, led by Professor Jason K. Sa from Korea University College of Medicine’s Department of Biomedical Informatics and Professor Jong Bae Park from the National Cancer Center, has elucidated the evolutionary process of glioblastoma recurrence through integrative proteogenomic analysis. They have provided new treatment opportunities based on their findings.

 

Glioblastoma is known for its complex genetic alterations and cellular capability to interact with surrounding neurons. It is particularly challenging due to its high recurrence rate and the prevalent resistance to standard treatments like chemotherapy and radiation therapy.

 

The research team meticulously analyzed the genomic, transcriptomic, and proteomic profiles of matched primary and recurrent glioblastoma from 123 patients. They discovered that The recurrent tumors have undergone neuronal transition*** through activation of the WNT/PCP signaling pathway* and the BRAF protein kinase**. The study also illustrated, through experimental validation with patient-derived cells and animal models, that the formation of synapses between normal neurons with tumor cells constituted a critical role in the recurrent tumor’s resistance to standard therapy.

 

​***Neuronal transition: The interaction between cancer cells and nerve cells through neurotransmitters significantly affects the growth, progression, and metastasis of cancer. 

​*WNT/PCP signaling pathway: This signaling pathway is crucial for regulating cell growth, movement, and differentiation and is associated with the development of various diseases, including cancer.

**BRAF protein kinase: As a Raf kinase, It plays a key role in activating the MAP/ERK signaling pathway, significantly impacting cancer cell survival, growth, and differentiation.

 

 

Moreover, The research highlighted that administering vemurafenib, a BRAF-inhibiting targeted drug, with temozolomide, a conventional chemotherapy drug, effectively impaired the neuronal transition and invasive capacity of the recurrent tumor cells, significantly prolonging survival in animal models. This outcome validates targeting the BRAF protein kinase as a novel strategy for combating recurrent glioblastoma, paving the way for innovative treatment opportunities.

 

Professor Sa stated, “The challenge with traditional genomic analysis was its inability to fully decipher the patterns of tumor evolution. This research, however, leverages a multidimensional data analysis approach, offering new therapeutic possibilities.”

 

Professor Park explained, “This is the first time that we’ve been able to demonstrate, through the integration of genomic, proteomic, and clinical data, the role of neuron-brain tumor cell network formation in the recurrence of brain tumors.”

 

Supported by the National Cancer Center’s Cancer Proteogenomic Research Project, this study has been featured in the renowned international journal Cancer Cell (IF=50.3), under the title ‘Integrated proteogenomic characterization of glioblastoma evolution.’

 



Journal

Cancer Cell

DOI

10.1016/j.ccell.2023.12.015

Method of Research

Experimental study

Subject of Research

Cells

Article Title

Integrated proteogenomic characterization of glioblastoma evolution

Article Publication Date

11-Mar-2024

COI Statement

none

Share26Tweet17
Previous Post

A study reveals the need to review temperature control measures in hospitals to manage legionella

Next Post

First detection of hepatitis E virus from urban Norway rats (Rattus norvegicus) in the Republic of Korea

Related Posts

blank
Cancer

Phase II Trial: Single vs Hypofractionated Breast Radiotherapy

August 8, 2025
blank
Cancer

Exploring Costochondral Junction Variations in Young Children

August 8, 2025
blank
Cancer

Weight Change Impact on Prostate Cancer Survival

August 8, 2025
blank
Cancer

Newborn Idiopathic Scrotal Hematoma: Case Study Insights

August 8, 2025
blank
Cancer

Symptomatic Progression-Free Survival: New Myeloma Measure

August 8, 2025
blank
Cancer

Revolutionary 3D CT Guide for Nasal Surgery

August 8, 2025
Next Post
photos of authors

First detection of hepatitis E virus from urban Norway rats (Rattus norvegicus) in the Republic of Korea

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27531 shares
    Share 11009 Tweet 6881
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    943 shares
    Share 377 Tweet 236
  • Bee body mass, pathogens and local climate influence heat tolerance

    641 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    507 shares
    Share 203 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Cutting the Global Toll of Liver Cancer: Key Insights from The Lancet Commission
  • Chinese Version Validated: São Paulo Sensory Scale
  • Phase II Trial: Single vs Hypofractionated Breast Radiotherapy
  • Financial Growth, Education, Industry Shape Ecological Footprints

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,858 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading